Neuble AI was founded by clinical faculty from Gangnam Severance Hospital, including radiologists and medical physicists, and is based in Seoul. The company develops medical imaging AI tools aimed at improving diagnostic precision and accessibility for degenerative brain conditions such as dementia. Its product pipeline includes BrainCura, an AI tool for volumetric brain measurement via CT scans, and SynCura, which synthesizes MRI-quality images from CT scans. Neuble AI raised $269,000 in a seed round led by Futureplay to fund regulatory submissions and prepare for commercial launch. The company is pursuing approvals from South Korea's MFDS, the U.S. FDA, and CE marking in Europe as part of its near-term go-to-market plan.

Total raised

$0M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2026